ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial.

Nirali N Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.